Skip to main content
Top
Published in: Lung 6/2017

01-12-2017 | COPD

The Influence of Body Composition on Pulmonary Rehabilitation Outcomes in Chronic Obstructive Pulmonary Disease Patients

Authors: Pichapong Tunsupon, M. Jeffery Mador

Published in: Lung | Issue 6/2017

Login to get access

Abstract

Introduction

Alterations in body composition are commonly present in chronic obstructive pulmonary disease (COPD). The hypothesis of this study is that COPD patients would achieve clinical benefits after pulmonary rehabilitation (PR) independent of muscle mass depletion or body weight.

Methods

We conducted a retrospective cohort study using single-frequency bioelectrical impedance analysis (BIA) for assessment of fat-free mass (FFM) depletion (muscle depletion). Patients were stratified into three categories based on (1) obesity BMI ≥ 30 kg/m2, (2) non-obesity BMI < 30 kg/m2, and (3) combined cachexia (BMI < 21 kg/m2 and FFM index < 16 kg/m2) and muscle atrophy (BMI ≥ 21 kg/m2 and FFMI < 16 kg/m2). PR outcomes were defined as the improvement in exercise capacity (maximal exercise capacity, 6-min walk, constant workload cycle exercise duration) and quality of life determined by Chronic Respiratory Questionnaire after PR.

Results

We studied 72 patients with available FFM measured by BIA. Patients were predominantly elderly man (N = 71; 98%), with a mean age of 72 years with COPD GOLD stage I–IV. The groups were balanced in terms of age, comorbidities, baseline FEV1, exercise capacity, and quality of life. The absolute changes in patients with muscle depletion or obesity compared to those without muscle depletion or obesity were not statistically different as was the percentage of patients reaching the minimal clinically important difference (MCID) after PR.

Conclusion

A comprehensive PR program in COPD patients improved exercise tolerance and quality of life independent of muscle mass depletion or obesity. Similarly, muscle depletion or obesity had no effect on the percentage of patients achieving the MCID for measures of quality of life and exercise tolerance after PR.
Literature
1.
go back to reference Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J et al (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173(12):1390–1413CrossRefPubMed Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J et al (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173(12):1390–1413CrossRefPubMed
2.
go back to reference Schols AM, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF (1991) Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 54(6):983–987PubMed Schols AM, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF (1991) Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 54(6):983–987PubMed
3.
go back to reference Engelen MP, Schols AM, Heidendal GA, Wouters EF (1998) Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 68(6):1298–1303PubMed Engelen MP, Schols AM, Heidendal GA, Wouters EF (1998) Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 68(6):1298–1303PubMed
4.
go back to reference Janssen I, Heymsfield SB, Baumgartner RN, Ross R (2000) Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 89(2):465–471PubMed Janssen I, Heymsfield SB, Baumgartner RN, Ross R (2000) Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 89(2):465–471PubMed
5.
go back to reference Schols AM, Wouters EF, Soeters PB, Westerterp KR (1991) Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 53(2):421–424PubMed Schols AM, Wouters EF, Soeters PB, Westerterp KR (1991) Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 53(2):421–424PubMed
6.
go back to reference Hughes RL, Katz H, Sahgal V, Campbell JA, Hartz R, Shields TW (1983) Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung diseases. Respiration 44(5):321–328CrossRefPubMed Hughes RL, Katz H, Sahgal V, Campbell JA, Hartz R, Shields TW (1983) Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung diseases. Respiration 44(5):321–328CrossRefPubMed
7.
go back to reference Gosker HR, Engelen MP, van Mameren H, van Dijk PJ, van der Vusse GJ, Wouters EF et al (2002) Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 76(1):113–119PubMed Gosker HR, Engelen MP, van Mameren H, van Dijk PJ, van der Vusse GJ, Wouters EF et al (2002) Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 76(1):113–119PubMed
8.
go back to reference Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP (1999) Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160(6):1856–1861CrossRefPubMed Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP (1999) Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160(6):1856–1861CrossRefPubMed
9.
go back to reference Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG (1996) Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153(3):961–966CrossRefPubMed Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG (1996) Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153(3):961–966CrossRefPubMed
10.
go back to reference Schols AM, Slangen J, Volovics L, Wouters EF (1998) Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(6 Pt 1):1791–1797CrossRefPubMed Schols AM, Slangen J, Volovics L, Wouters EF (1998) Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(6 Pt 1):1791–1797CrossRefPubMed
11.
go back to reference Cao C, Wang R, Wang J, Bunjhoo H, Xu Y, Xiong W (2012) Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS ONE 7(8):e43892CrossRefPubMedPubMedCentral Cao C, Wang R, Wang J, Bunjhoo H, Xu Y, Xiong W (2012) Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS ONE 7(8):e43892CrossRefPubMedPubMedCentral
12.
go back to reference Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA et al (2007) Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 131(5 Suppl):4s–42sCrossRefPubMed Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA et al (2007) Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 131(5 Suppl):4s–42sCrossRefPubMed
13.
go back to reference Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163(5):1256–1276CrossRefPubMed Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163(5):1256–1276CrossRefPubMed
14.
go back to reference Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF (2005) Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82(1):53–59PubMed Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF (2005) Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82(1):53–59PubMed
15.
go back to reference Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423CrossRefPubMedPubMedCentral Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423CrossRefPubMedPubMedCentral
16.
go back to reference VanItallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA (1990) Height-normalized indices of the body’s fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 52(6):953–959PubMed VanItallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA (1990) Height-normalized indices of the body’s fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 52(6):953–959PubMed
17.
go back to reference Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA et al (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350(10):1005–1012CrossRefPubMed Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA et al (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350(10):1005–1012CrossRefPubMed
18.
go back to reference Chauvin A, Rupley L, Meyers K, Johnson K, Eason J (2008) Outcomes in cardiopulmonary physical therapy: chronic respiratory disease questionnaire (CRQ). Cardiopulm Phys Ther J 19(2):61–67PubMedPubMedCentral Chauvin A, Rupley L, Meyers K, Johnson K, Eason J (2008) Outcomes in cardiopulmonary physical therapy: chronic respiratory disease questionnaire (CRQ). Cardiopulm Phys Ther J 19(2):61–67PubMedPubMedCentral
19.
go back to reference Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN et al (2011) The minimal important difference of exercise tests in severe COPD. Eur Respir J 37(4):784–790CrossRefPubMed Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN et al (2011) The minimal important difference of exercise tests in severe COPD. Eur Respir J 37(4):784–790CrossRefPubMed
20.
go back to reference Laviolette L, Bourbeau J, Bernard S, Lacasse Y, Pepin V, Breton MJ et al (2008) Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax 63(2):115–121CrossRefPubMed Laviolette L, Bourbeau J, Bernard S, Lacasse Y, Pepin V, Breton MJ et al (2008) Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax 63(2):115–121CrossRefPubMed
21.
go back to reference Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF (1993) Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147(5):1151–1156CrossRefPubMed Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF (1993) Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147(5):1151–1156CrossRefPubMed
22.
go back to reference Steiner MC, Barton RL, Singh SJ, Morgan MD (2002) Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 19(4):626–631CrossRefPubMed Steiner MC, Barton RL, Singh SJ, Morgan MD (2002) Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 19(4):626–631CrossRefPubMed
23.
go back to reference Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF (1994) Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 7(10):1793–1797CrossRefPubMed Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF (1994) Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 7(10):1793–1797CrossRefPubMed
24.
go back to reference Jones SE, Maddocks M, Kon SS, Canavan JL, Nolan CM, Clark AL et al (2015) Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 70(3):213–218CrossRefPubMed Jones SE, Maddocks M, Kon SS, Canavan JL, Nolan CM, Clark AL et al (2015) Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 70(3):213–218CrossRefPubMed
25.
go back to reference Legrand D, Vaes B, Mathei C, Swine C, Degryse JM (2013) The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing 42(6):727–734CrossRefPubMed Legrand D, Vaes B, Mathei C, Swine C, Degryse JM (2013) The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing 42(6):727–734CrossRefPubMed
27.
go back to reference Arora NS, Rochester DF (1982) Respiratory muscle strength and maximal voluntary ventilation in undernourished patients. Am Rev Respir Dis 126(1):5–8PubMed Arora NS, Rochester DF (1982) Respiratory muscle strength and maximal voluntary ventilation in undernourished patients. Am Rev Respir Dis 126(1):5–8PubMed
28.
go back to reference Rochester DF, Braun NM (1985) Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 132(1):42–47PubMed Rochester DF, Braun NM (1985) Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 132(1):42–47PubMed
29.
go back to reference Derenne JP, Macklem PT, Roussos C (1978) The respiratory muscles: mechanics, control, and pathophysiology. Am Rev Respir Dis 118(1):119–133PubMed Derenne JP, Macklem PT, Roussos C (1978) The respiratory muscles: mechanics, control, and pathophysiology. Am Rev Respir Dis 118(1):119–133PubMed
30.
go back to reference Van Helvoort HA, Heijdra YF, Thijs HM, Vina J, Wanten GJ, Dekhuijzen PN (2006) Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc 38(9):1543–1552CrossRefPubMed Van Helvoort HA, Heijdra YF, Thijs HM, Vina J, Wanten GJ, Dekhuijzen PN (2006) Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc 38(9):1543–1552CrossRefPubMed
31.
go back to reference Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C et al (2003) Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167(12):1664–1669CrossRefPubMed Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C et al (2003) Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167(12):1664–1669CrossRefPubMed
32.
go back to reference Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R et al (2014) An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 189(9):e15–e62CrossRefPubMedPubMedCentral Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R et al (2014) An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 189(9):e15–e62CrossRefPubMedPubMedCentral
33.
go back to reference Bernard S, Whittom F, Leblanc P, Jobin J, Belleau R, Berube C et al (1999) Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159(3):896–901CrossRefPubMed Bernard S, Whittom F, Leblanc P, Jobin J, Belleau R, Berube C et al (1999) Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159(3):896–901CrossRefPubMed
34.
go back to reference Berton DC, Silveira L, Da Costa CC, De Souza RM, Winter CD, Zimermann Teixeira PJ (2013) Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion. Arch Phys Med Rehabil 94(8):1607–1614CrossRefPubMed Berton DC, Silveira L, Da Costa CC, De Souza RM, Winter CD, Zimermann Teixeira PJ (2013) Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion. Arch Phys Med Rehabil 94(8):1607–1614CrossRefPubMed
35.
go back to reference Mador MJ, Bozkanat E, Aggarwal A, Shaffer M, Kufel TJ (2004) Endurance and strength training in patients with COPD. Chest 125(6):2036–2045CrossRefPubMed Mador MJ, Bozkanat E, Aggarwal A, Shaffer M, Kufel TJ (2004) Endurance and strength training in patients with COPD. Chest 125(6):2036–2045CrossRefPubMed
36.
go back to reference Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A et al (2003) The 6-min walk test: a quick measure of functional status in elderly adults. Chest 123(2):387–398CrossRefPubMed Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A et al (2003) The 6-min walk test: a quick measure of functional status in elderly adults. Chest 123(2):387–398CrossRefPubMed
37.
go back to reference Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B (2008) The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chronic Respir Dis 5(4):205–209CrossRef Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B (2008) The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chronic Respir Dis 5(4):205–209CrossRef
38.
go back to reference Seres L, Lopez-Ayerbe J, Coll R, Rodriguez O, Manresa JM, Marrugat J et al (2003) Cardiopulmonary function and exercise capacity in patients with morbid obesity. Rev Esp Cardiol 56(6):594–600CrossRefPubMed Seres L, Lopez-Ayerbe J, Coll R, Rodriguez O, Manresa JM, Marrugat J et al (2003) Cardiopulmonary function and exercise capacity in patients with morbid obesity. Rev Esp Cardiol 56(6):594–600CrossRefPubMed
39.
go back to reference Garrod R, Marshall J, Barley E, Jones PW (2006) Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 27(4):788–794CrossRefPubMed Garrod R, Marshall J, Barley E, Jones PW (2006) Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 27(4):788–794CrossRefPubMed
40.
go back to reference Beauchamp MK, Evans R, Janaudis-Ferreira T, Goldstein RS, Brooks D (2013) Systematic review of supervised exercise programs after pulmonary rehabilitation in individuals with COPD. Chest 144(4):1124–1133CrossRefPubMed Beauchamp MK, Evans R, Janaudis-Ferreira T, Goldstein RS, Brooks D (2013) Systematic review of supervised exercise programs after pulmonary rehabilitation in individuals with COPD. Chest 144(4):1124–1133CrossRefPubMed
Metadata
Title
The Influence of Body Composition on Pulmonary Rehabilitation Outcomes in Chronic Obstructive Pulmonary Disease Patients
Authors
Pichapong Tunsupon
M. Jeffery Mador
Publication date
01-12-2017
Publisher
Springer US
Published in
Lung / Issue 6/2017
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-017-0053-y

Other articles of this Issue 6/2017

Lung 6/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.